Peng Z, Gao X M, Zhou S, Wu C Y, Zhao J L, Xu D, Li M T, Peng J M, Li J, Wang Q, Tian X F, Zeng Xiaofeng
Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.
Department of Medical ICU, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital (PUMCH), Beijing 100730, China.
Zhonghua Yi Xue Za Zhi. 2022 Jul 26;102(28):2210-2214. doi: 10.3760/cma.j.cn112137-20220321-00602.
The data of 33 patients with adult-onset still's disease (AOSD)-associated macrophage activation syndrome (MAS) were retrospectively collected from January 2013 to December 2020 in Peking Union Medical College Hospital. Hemophagocytic lymphohistiocytosis (HLH)-2004 criteria, macrophage activation syndrome/juvenile idiopathic arthritis (MS-Score) and hemophagocytic syndrome diagnostic score (HScore) were used to diagnose AOSD-associated MAS, respectively. The time of diagnosis of AOSD-associated MAS by MS-Score was 19.0 (4.5, 31.0) days [,)] earlier than by HLH-2004 criteria, and 13.5 (0.5, 21.5) days earlier than by HScore (both <0.05). The difference was not statistically significant between the time of diagnosis of AOSD-associated MAS by Hscore and by HLH-2004 criteria (0.05). There was significant difference among the three criteria (<0.001). MS-Score can be used to diagnose AOSD-associated MAS earlier than HLH-2004 criteria, while the timeliness of HScore is not certain.
回顾性收集2013年1月至2020年12月在北京协和医院就诊的33例成人起病的斯蒂尔病(AOSD)相关巨噬细胞活化综合征(MAS)患者的数据。分别采用噬血细胞性淋巴组织细胞增生症(HLH)-2004标准、巨噬细胞活化综合征/幼年特发性关节炎(MS评分)和噬血细胞综合征诊断评分(HScore)诊断AOSD相关的MAS。采用MS评分诊断AOSD相关MAS的时间比采用HLH-2004标准早19.0(4.5,31.0)天[,)],比采用HScore早13.5(0.5,21.5)天(均<0.05)。采用HScore和HLH-2004标准诊断AOSD相关MAS的时间差异无统计学意义(0.05)。三项标准之间存在显著差异(<0.001)。与HLH-2004标准相比,MS评分可更早用于诊断AOSD相关的MAS,而HScore的及时性尚不确定。